Macrogen

Macrogen EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Macrogen (038290.KQ) as of Nov 9, 2026 is -15.49. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -8.25 — a change of 87.81% (lower).

EV/FCF

-15.49

YoY

87.81%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Macrogen is 2025 -15.49 . EV/FCF (Enterprise Value to Free Cash Flow) of Macrogen was 2024 -8.25 . It decreases by 87.81% lower compared to the previous year.

The Macrogen EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
14.92 KRW
Jan 1, 2019
-3.88 KRW
Jan 1, 2020
83.10 KRW
Jan 1, 2021
14.61 KRW
Jan 1, 2022
-21.03 KRW
Jan 1, 2023
-10.83 KRW
Jan 1, 2024
-8.25 KRW
Jan 1, 2025
-15.49 KRW
The Macrogen EV/FCF history
YEAREV/FCFYoY
-15.49+87.81%
-8.25-23.86%
-10.83-48.49%
-21.03-243.95%
14.61-82.42%
83.10-2,241.79%
-3.88-126.00%
14.92-81.68%
81.45+195.40%
27.57-140.30%
-68.43+380.70%
-14.23—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Macrogen Stock analysis

What does Macrogen do? Macrogen Inc. generates revenue through its four business divisions. The DNA sequencing division provides genome sequencing analysis services to clients requiring genetic data processing. The DNA chips division sells products including Illumina chips, MacArray chips, and customized chips to research institutions and biotech firms. The transgenic and knockout mouse division offers gene engineering services to pharmaceutical companies and academic laboratories. The oligonucleotide DNA division supplies oligonucleotide DNA manufacturing services to biotechnology clients. All services are delivered domestically and internationally to established market segments. The company's DNA chips division markets specific branded products like Illumina chips and MacArray chips, which are purchased by research organizations and biotechnology enterprises. Gene engineering services from the transgenic division are bought by pharmaceutical companies seeking to develop new treatments. Oligonucleotide DNA manufacturing services target biotech clients needing specialized DNA synthesis. Domestic and overseas markets represent the primary customer segments for all divisions. Macrogen's product portfolio includes DNA sequencing services, DNA chip products, gene engineering solutions, and oligonucleotide DNA manufacturing. Clients include research institutions, pharmaceutical companies, academic laboratories, and biotechnology firms. The DNA chips division's branded products are specifically named in the description, while other services are described by their technical functions. Market segments are defined by the company's domestic and international operations. Macrogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Macrogen stock

EV/FCF (Enterprise Value to Free Cash Flow) of Macrogen is -15.49 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Macrogen changed from -8.25 to -15.49, representing a 87.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Macrogen since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Macrogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Macrogen

All Key Metrics — Macrogen